CSL tied up the Vifor acquisition today.
There's been some speculation here that the appointment of Dr Elliot to the PIQ board could indicate that PIQ is on CSL's radar as a potentially complementary business.
Will be interesting to see what the stated strategy will be going forward.
Ann: Clinical Utility Study demonstrates PromarkerD test benefits, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
-0.010(1.30%) |
Mkt cap ! $99.56M | |||
| Open | High | Low | Value | Volume |
| 77.0¢ | 77.0¢ | 75.3¢ | $271.7K | 355.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 717 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 1298 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |